Adam Marks

Adam Marks is an MD/PhD candidate at the Icahn School of Medicine at Mount Sinai, where his PhD work in the Brown Lab focuses on genetics & gene therapy, immunology, and drug delivery. His research centers on developing tissue- and cell-targeted delivery platforms for RNA-based therapies to better understand the interface between immunization and immune tolerance. He graduated from McGill University in 2016 with a Bachelor of Science in Biochemistry and has previously conducted research at The Rockefeller University and University College London.